메뉴 건너뛰기
Clinical Therapeutics
Volumn 24, Issue 9, 2002, Pages 1477-1480
Letters to the editor (multiple letters)
Author keywords

[No Author keywords available]
Indexed keywords

DEXAMETHASONE; FLUOROMETHOLONE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN FUMARATE; LOTEPREDNOL ETABONATE; OLOPATADINE; ANDROSTANE DERIVATIVE; ANTIINFLAMMATORY AGENT; DIBENZOXEPIN DERIVATIVE; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT;
EID: 0036750581     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)80051-0     Document Type: Letter
Times cited : (2)
References (7)
  • 1
    • 0035986660 scopus 로고    scopus 로고
    • Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model
    • GJ Berdy JO Stoppel AB Epstein Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model Clin Ther 24 2002 918 929
    • (2002) Clin Ther , vol.24 , pp. 918-929
    • Berdy, GJ1    Stoppel, JO2    Epstein, AB3
  • 2
    • 0031700446 scopus 로고    scopus 로고
    • The conjunctival provocation test model of ocular allergy: Utility for assessment of an ocular corticosteroid, loteprednol etabonate
    • M Abelson J Howes M George The conjunctival provocation test model of ocular allergy: Utility for assessment of an ocular corticosteroid, loteprednol etabonate J Ocul Pharmacol Ther 14 1998 533 542
    • (1998) J Ocul Pharmacol Ther , vol.14 , pp. 533-542
    • Abelson, M1    Howes, J2    George, M3
  • 3
    • 0031722635 scopus 로고    scopus 로고
    • A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis
    • SJ Dell GM Lowry JA Northcutt A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis J Allergy Clin Immunol 102 1998 251 255
    • (1998) J Allergy Clin Immunol , vol.102 , pp. 251-255
    • Dell, SJ1    Lowry, GM2    Northcutt, JA3
  • 4
    • 0033511435 scopus 로고    scopus 로고
    • A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis
    • DG Shulman LL Lothringer JM Rubin A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis Ophthalmology 106 1999 362 369
    • (1999) Ophthalmology , vol.106 , pp. 362-369
    • Shulman, DG1    Lothringer, LL2    Rubin, JM3
  • 5
    • 85120129464 scopus 로고    scopus 로고
    • AJ Aguilar Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate 2000 52 55 230
    • (2000) , pp. 52-55
    • Aguilar, AJ1
  • 6
    • 0021243642 scopus 로고
    • Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate
    • RH Stewart JP Smith AL Rosenthal Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate Curr Eye Res 3 1984 835 839
    • (1984) Curr Eye Res , vol.3 , pp. 835-839
    • Stewart, RH1    Smith, JP2    Rosenthal, AL3
  • 7
    • 0032467764 scopus 로고    scopus 로고
    • Change in intraocular pressure during long-term use of loteprednol etabonate
    • GD Novack J Howes RS Crockett MB Sherwood Change in intraocular pressure during long-term use of loteprednol etabonate J Glaucoma 7 1998 266 269
    • (1998) J Glaucoma , vol.7 , pp. 266-269
    • Novack, GD1    Howes, J2    Crockett, RS3    Sherwood, MB4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.